Long, H. J., Nelimark, R. A., Su, J. Q., Garneau, S. C., Levitt, R., Goldberg, R. M., . . . Kugler, J. W. (1994). Phase II Evaluation of 5-Fluorouracil and Low-Dose Leucovorin in Cisplatin-Refractory Advanced Ovarian Carcinoma. Gynecologic Oncology, 54(2), 180-183. https://doi.org/10.1006/gyno.1994.1190
Chicago Style (17th ed.) CitationLong, Harry J., Robert A. Nelimark, John Q. Su, Stewart C. Garneau, Ralph Levitt, Richard M. Goldberg, Michael A. Poon, and John W. Kugler. "Phase II Evaluation of 5-Fluorouracil and Low-Dose Leucovorin in Cisplatin-Refractory Advanced Ovarian Carcinoma." Gynecologic Oncology 54, no. 2 (1994): 180-183. https://doi.org/10.1006/gyno.1994.1190.
MLA (8th ed.) CitationLong, Harry J., et al. "Phase II Evaluation of 5-Fluorouracil and Low-Dose Leucovorin in Cisplatin-Refractory Advanced Ovarian Carcinoma." Gynecologic Oncology, vol. 54, no. 2, 1994, pp. 180-183, https://doi.org/10.1006/gyno.1994.1190.
Visit our Citation Styles guide for help on properly citing sources.